Trends in Black and White Opioid Mortality in the United States, 1979-2015
Recent research on the US opioid epidemic has focused on the white or total population and has largely been limited to data after 1999. However, understanding racial differences in long-term trends by opioid type may contribute to improving interventions. Using multiple cause of death data, we calcu...
Gespeichert in:
| Veröffentlicht in: | Epidemiology (Cambridge, Mass.) Jg. 29; H. 5; S. 707 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
United States
01.09.2018
|
| Schlagworte: | |
| ISSN: | 1531-5487, 1531-5487 |
| Online-Zugang: | Weitere Angaben |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Recent research on the US opioid epidemic has focused on the white or total population and has largely been limited to data after 1999. However, understanding racial differences in long-term trends by opioid type may contribute to improving interventions.
Using multiple cause of death data, we calculated age-standardized opioid mortality rates, by race and opioid type, for the US resident population from 1979 to 2015. We analyzed trends in mortality rates using joinpoint regression.
From 1979 to 2015, the long-term trends in opioid-related mortality for Earlier data did not include ethnicity so this is incorrect. It is all black and all white residents in the US. blacks and whites went through three successive waves. In the first wave, from 1979 to the mid-1990s, the epidemic affected both populations and was driven by heroin. In the second wave, from the mid-1990s to 2010, the increase in opioid mortality was driven by natural/semi-synthetic opioids (e.g., codeine, morphine, hydrocodone, or oxycodone) among whites, while there was no increase in mortality for blacks. In the current wave, increases in opioid mortality for both populations have been driven by heroin and synthetic opioids (e.g., fentanyl and its analogues). Heroin rates are currently increasing at 31% (95% confidence interval [CI] = 27, 35) per year for whites and 34% (95% CI = 30, 40) for blacks. Concurrently, respective synthetic opioids are increasing at 79% (95% CI = 50, 112) and 107% (95% CI = -15, 404) annually.
Since 1979, the nature of the opioid epidemic has shifted from heroin to prescription opioids for the white population to increasing of heroin/synthetic deaths for both black and white populations. See video abstract at, http://links.lww.com/EDE/B377. |
|---|---|
| AbstractList | Recent research on the US opioid epidemic has focused on the white or total population and has largely been limited to data after 1999. However, understanding racial differences in long-term trends by opioid type may contribute to improving interventions.BACKGROUNDRecent research on the US opioid epidemic has focused on the white or total population and has largely been limited to data after 1999. However, understanding racial differences in long-term trends by opioid type may contribute to improving interventions.Using multiple cause of death data, we calculated age-standardized opioid mortality rates, by race and opioid type, for the US resident population from 1979 to 2015. We analyzed trends in mortality rates using joinpoint regression.METHODSUsing multiple cause of death data, we calculated age-standardized opioid mortality rates, by race and opioid type, for the US resident population from 1979 to 2015. We analyzed trends in mortality rates using joinpoint regression.From 1979 to 2015, the long-term trends in opioid-related mortality for Earlier data did not include ethnicity so this is incorrect. It is all black and all white residents in the US. blacks and whites went through three successive waves. In the first wave, from 1979 to the mid-1990s, the epidemic affected both populations and was driven by heroin. In the second wave, from the mid-1990s to 2010, the increase in opioid mortality was driven by natural/semi-synthetic opioids (e.g., codeine, morphine, hydrocodone, or oxycodone) among whites, while there was no increase in mortality for blacks. In the current wave, increases in opioid mortality for both populations have been driven by heroin and synthetic opioids (e.g., fentanyl and its analogues). Heroin rates are currently increasing at 31% (95% confidence interval [CI] = 27, 35) per year for whites and 34% (95% CI = 30, 40) for blacks. Concurrently, respective synthetic opioids are increasing at 79% (95% CI = 50, 112) and 107% (95% CI = -15, 404) annually.RESULTSFrom 1979 to 2015, the long-term trends in opioid-related mortality for Earlier data did not include ethnicity so this is incorrect. It is all black and all white residents in the US. blacks and whites went through three successive waves. In the first wave, from 1979 to the mid-1990s, the epidemic affected both populations and was driven by heroin. In the second wave, from the mid-1990s to 2010, the increase in opioid mortality was driven by natural/semi-synthetic opioids (e.g., codeine, morphine, hydrocodone, or oxycodone) among whites, while there was no increase in mortality for blacks. In the current wave, increases in opioid mortality for both populations have been driven by heroin and synthetic opioids (e.g., fentanyl and its analogues). Heroin rates are currently increasing at 31% (95% confidence interval [CI] = 27, 35) per year for whites and 34% (95% CI = 30, 40) for blacks. Concurrently, respective synthetic opioids are increasing at 79% (95% CI = 50, 112) and 107% (95% CI = -15, 404) annually.Since 1979, the nature of the opioid epidemic has shifted from heroin to prescription opioids for the white population to increasing of heroin/synthetic deaths for both black and white populations. See video abstract at, http://links.lww.com/EDE/B377.CONCLUSIONSince 1979, the nature of the opioid epidemic has shifted from heroin to prescription opioids for the white population to increasing of heroin/synthetic deaths for both black and white populations. See video abstract at, http://links.lww.com/EDE/B377. Recent research on the US opioid epidemic has focused on the white or total population and has largely been limited to data after 1999. However, understanding racial differences in long-term trends by opioid type may contribute to improving interventions. Using multiple cause of death data, we calculated age-standardized opioid mortality rates, by race and opioid type, for the US resident population from 1979 to 2015. We analyzed trends in mortality rates using joinpoint regression. From 1979 to 2015, the long-term trends in opioid-related mortality for Earlier data did not include ethnicity so this is incorrect. It is all black and all white residents in the US. blacks and whites went through three successive waves. In the first wave, from 1979 to the mid-1990s, the epidemic affected both populations and was driven by heroin. In the second wave, from the mid-1990s to 2010, the increase in opioid mortality was driven by natural/semi-synthetic opioids (e.g., codeine, morphine, hydrocodone, or oxycodone) among whites, while there was no increase in mortality for blacks. In the current wave, increases in opioid mortality for both populations have been driven by heroin and synthetic opioids (e.g., fentanyl and its analogues). Heroin rates are currently increasing at 31% (95% confidence interval [CI] = 27, 35) per year for whites and 34% (95% CI = 30, 40) for blacks. Concurrently, respective synthetic opioids are increasing at 79% (95% CI = 50, 112) and 107% (95% CI = -15, 404) annually. Since 1979, the nature of the opioid epidemic has shifted from heroin to prescription opioids for the white population to increasing of heroin/synthetic deaths for both black and white populations. See video abstract at, http://links.lww.com/EDE/B377. |
| Author | Kiang, Mathew V Alexander, Monica J Barbieri, Magali |
| Author_xml | – sequence: 1 givenname: Monica J surname: Alexander fullname: Alexander, Monica J organization: From the Department of Demography, University of California, Berkeley, Berkeley, CA – sequence: 2 givenname: Mathew V surname: Kiang fullname: Kiang, Mathew V organization: Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, MA – sequence: 3 givenname: Magali surname: Barbieri fullname: Barbieri, Magali organization: Institut national d'études démographiques, Paris, France |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29847496$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNj0lPwzAUhC1URBf4Bwj5yIEUL_GSI5SwqagHWnGMTPyiGlInxM6h_55WFKlzmaeZT0-aMRr4xgNCl5RMKcnUbf6QT8mxtNAnaEQFp4lItRoc3UM0DuGLEKo4FWdoyDKdqjSTI_S67MDbgJ3H97Upv7HxFn-sXQS8aF3jLH5rumhqF7d7Jq4Br_yutfg9mgjhBtNMZQkjVJyj08rUAS4OPkGrx3w5e07mi6eX2d08KQVVOqkINdyUQhueWkOZBcI0rSQDLqS2-0hq4EDAlrQyVmnClbSpFGBtWRk2Qdd_f9uu-ekhxGLjQgl1bTw0fSgYSVXGJJdih14d0P5zA7ZoO7cx3bb4389-AaeVXMc |
| CitedBy_id | crossref_primary_10_1016_j_drugpo_2019_07_008 crossref_primary_10_1177_00220426221121121 crossref_primary_10_1097_EDE_0000000000000965 crossref_primary_10_1177_1178221819866211 crossref_primary_10_1093_aje_kwae156 crossref_primary_10_1016_j_jeem_2022_102696 crossref_primary_10_1186_s12916_020_01575_0 crossref_primary_10_1007_s40615_021_01007_6 crossref_primary_10_1016_j_peptides_2021_170547 crossref_primary_10_1093_qje_qjab043 crossref_primary_10_1016_j_annepidem_2021_08_015 crossref_primary_10_1111_acer_14239 crossref_primary_10_4054_DemRes_2025_52_18 crossref_primary_10_1001_jamahealthforum_2023_3274 crossref_primary_10_1371_journal_pmed_1002956 crossref_primary_10_1016_j_abrep_2020_100316 crossref_primary_10_1016_j_drugpo_2024_104435 crossref_primary_10_1097_ADM_0000000000000523 crossref_primary_10_1007_s11606_020_05645_0 crossref_primary_10_1007_s40615_025_02554_y crossref_primary_10_12788_jhm_3703 crossref_primary_10_1111_add_14750 crossref_primary_10_1146_annurev_publhealth_090419_102727 crossref_primary_10_1136_bmjph_2023_000480 crossref_primary_10_1213_ANE_0000000000006058 crossref_primary_10_1016_j_amepre_2019_09_022 crossref_primary_10_1016_j_addbeh_2021_107113 crossref_primary_10_1080_15564886_2020_1750517 crossref_primary_10_1016_S0140_6736_20_32545_9 crossref_primary_10_1111_1475_6773_13968 crossref_primary_10_1016_j_drugalcdep_2021_108666 crossref_primary_10_1371_journal_pmed_1002969 crossref_primary_10_1007_s40615_020_00901_9 crossref_primary_10_1097_QAD_0000000000003688 crossref_primary_10_1016_j_annemergmed_2019_05_018 crossref_primary_10_1097_ADM_0000000000000814 crossref_primary_10_1001_jamanetworkopen_2025_2728 crossref_primary_10_1111_padr_12336 crossref_primary_10_1038_s41372_019_0440_8 crossref_primary_10_1177_0033354919878158 crossref_primary_10_1089_heq_2020_0062 crossref_primary_10_1002_clc_70129 crossref_primary_10_1001_jamanetworkopen_2020_6745 crossref_primary_10_1002_soej_12481 crossref_primary_10_2105_AJPH_2021_306503 crossref_primary_10_1016_j_drugalcdep_2021_108632 crossref_primary_10_1016_S0140_6736_20_32017_1 crossref_primary_10_1016_j_drugalcdep_2021_108755 crossref_primary_10_1215_00703370_9772414 crossref_primary_10_2105_AJPH_2019_305049 crossref_primary_10_1136_jech_2019_212915 crossref_primary_10_1111_padr_12625 crossref_primary_10_1016_j_cpr_2021_101978 crossref_primary_10_1016_j_amepre_2019_09_008 crossref_primary_10_4054_DemRes_2025_52_3 crossref_primary_10_1016_j_ssmmh_2024_100381 crossref_primary_10_1016_j_jsat_2021_108563 crossref_primary_10_1016_j_drugalcdep_2019_107615 crossref_primary_10_1093_hsw_hlae019 crossref_primary_10_1057_s41292_021_00230_y crossref_primary_10_1186_s12954_023_00893_9 crossref_primary_10_1080_02791072_2019_1599472 crossref_primary_10_1016_j_jpainsymman_2020_08_015 crossref_primary_10_1377_hlthaff_2025_00357 crossref_primary_10_1093_aje_kwy280 crossref_primary_10_1016_j_socscimed_2025_118132 crossref_primary_10_1001_jamapediatrics_2020_5205 crossref_primary_10_1016_j_pmn_2024_12_019 crossref_primary_10_1007_s12076_023_00350_y crossref_primary_10_1177_00027162211009776 crossref_primary_10_1177_10664807251322171 crossref_primary_10_1097_HRP_0000000000000285 crossref_primary_10_1093_aje_kwab088 crossref_primary_10_1093_ofid_ofac142 crossref_primary_10_1080_10826084_2022_2064507 crossref_primary_10_1111_dar_13832 crossref_primary_10_1097_EDE_0000000000001299 crossref_primary_10_1177_1088767919849643 crossref_primary_10_1016_j_ajog_2018_09_028 crossref_primary_10_2147_JPR_S308196 crossref_primary_10_1016_j_drugalcdep_2020_108059 crossref_primary_10_1016_j_ajem_2021_10_017 crossref_primary_10_1016_j_amepre_2021_10_009 crossref_primary_10_1007_s11524_020_00439_5 crossref_primary_10_1111_padr_70018 crossref_primary_10_1016_S0140_6736_24_01495_8 crossref_primary_10_1016_j_drugalcdep_2022_109309 crossref_primary_10_1001_jamanetworkopen_2019_0040 crossref_primary_10_1016_j_lana_2022_100237 crossref_primary_10_1136_bmjopen_2019_035376 crossref_primary_10_1215_00703370_8937348 crossref_primary_10_1038_s41598_020_61281_y crossref_primary_10_1016_j_drugalcdep_2019_107598 crossref_primary_10_1097_JHQ_0000000000000381 crossref_primary_10_1177_0162243920912812 crossref_primary_10_2147_JPR_S287314 crossref_primary_10_3389_frcha_2025_1600101 crossref_primary_10_1080_08998280_2025_2546764 crossref_primary_10_1177_00220426231168081 crossref_primary_10_1177_23780231241275429 crossref_primary_10_12998_wjcc_v11_i11_2374 crossref_primary_10_1007_s11524_021_00573_8 crossref_primary_10_1016_j_drugalcdep_2020_108321 crossref_primary_10_1016_j_drugalcdep_2021_108588 crossref_primary_10_1146_annurev_soc_030320_031757 crossref_primary_10_1093_jrsssa_qnac001 crossref_primary_10_1097_01_EEM_0000000000000031 crossref_primary_10_1177_0033354920968806 crossref_primary_10_1017_S002187582100027X crossref_primary_10_1371_journal_pone_0226490 crossref_primary_10_1016_j_drugalcdep_2020_108207 crossref_primary_10_1186_s12889_023_17563_x crossref_primary_10_1177_00220426221093610 crossref_primary_10_1016_j_amepre_2024_12_020 crossref_primary_10_1080_09581596_2019_1626002 crossref_primary_10_1146_annurev_soc_072320_100249 crossref_primary_10_1111_wvn_12419 crossref_primary_10_1080_17445647_2023_2270632 crossref_primary_10_1016_S2215_0366_23_00119_0 crossref_primary_10_3390_pharmacy8020074 crossref_primary_10_1016_j_drugalcdep_2021_109242 crossref_primary_10_1097_EDE_0000000000001199 crossref_primary_10_1215_00703370_10346963 crossref_primary_10_1097_EDE_0000000000001597 crossref_primary_10_1007_s00127_025_02897_1 crossref_primary_10_1080_24734306_2022_2110201 crossref_primary_10_2105_AJPH_2019_305002 crossref_primary_10_1146_annurev_publhealth_082619_104231 crossref_primary_10_1016_j_ajo_2021_04_030 crossref_primary_10_1097_CORR_0000000000002414 crossref_primary_10_1371_journal_pone_0332210 crossref_primary_10_1080_15332640_2023_2278469 crossref_primary_10_1089_jpm_2021_0502 crossref_primary_10_1096_fj_202002125R crossref_primary_10_1097_QAI_0000000000002545 crossref_primary_10_7759_cureus_48690 crossref_primary_10_1017_S1742058X20000028 crossref_primary_10_1111_ecin_12819 crossref_primary_10_1073_pnas_2205813119 crossref_primary_10_1080_08897077_2020_1740379 crossref_primary_10_1016_j_drugalcdep_2019_107658 crossref_primary_10_1016_j_drugalcdep_2022_109555 crossref_primary_10_1080_10920277_2023_2167834 crossref_primary_10_1016_j_ypmed_2024_108010 crossref_primary_10_1007_s40615_022_01384_6 crossref_primary_10_1007_s00148_025_01108_0 crossref_primary_10_1016_j_drugalcdep_2021_108849 crossref_primary_10_1016_j_jemermed_2025_08_009 crossref_primary_10_1007_s11113_025_09952_4 crossref_primary_10_1007_s11469_024_01306_z crossref_primary_10_1111_ajad_13092 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1097/EDE.0000000000000858 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Public Health |
| EISSN | 1531-5487 |
| ExternalDocumentID | 29847496 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GeographicLocations | United States |
| GeographicLocations_xml | – name: United States |
| GrantInformation_xml | – fundername: NIA NIH HHS grantid: R01 AG040245 – fundername: NIA NIH HHS grantid: R01 AG011552 |
| GroupedDBID | --- .-D .55 .Z2 01R 0R~ 1J1 40H 4Q1 4Q2 4Q3 53G 5GY 5VS 71W 77Y 7O~ 8L- AAAAV AAAXR AACGO AAGIX AAHPQ AAIKC AAIQE AAMNW AAMOA AAMTA AANCE AAQKA AARTV AASCR AASOK AAXQO AAYEP ABASU ABBHK ABBUW ABDIG ABJNI ABPLY ABTLG ABVCZ ABXSQ ABXVJ ABZAD ACCJW ACDDN ACEWG ACGFO ACGFS ACHIC ACHQT ACIJW ACILI ACLDA ACWDW ACWRI ACXJB ACXNZ ADFPA ADGGA ADHPY ADNKB ADULT AE3 AE6 AEETU AENEX AEUPB AEXZC AFDTB AFFNX AFUWQ AGINI AHOMT AHQNM AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJNYG AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI ANHSF AOHHW AQVQM AWKKM BOYCO BQLVK BS7 BYPQX C45 CGR CS3 CUY CVF DCCCD DIWNM DOOOF DU5 DUNZO E.X EBS ECM EEVPB EIF EJD EQZMY ERAAH EX3 F2M F2N F5P FCALG FL- FW0 GNXGY GQDEL H0~ HGD HLJTE HQ3 HTVGU HZ~ IKREB IKYAY IN~ IPNFZ IPSME JAAYA JBMMH JENOY JF9 JG8 JHFFW JK3 JK8 JKQEH JLS JLXEF JPM JSG JSODD JST K8S KD2 L-C N9A NPM N~7 N~B N~M O9- OAG OAH OCUKA ODA OJAPA OLG OLH OLU OLW OLY OPUJH ORVUJ OUVQU OVD OVDNE OVIDH OVLEI OWU OWV OWW OWX OWY OWZ OXXIT P-K P2P R58 RIG RLZ S4R S4S SA0 T8P TEORI TSPGW V2I VVN W3M WOQ WOW X3V X3W X7M XXN XYM YCJ YOC ZFV ZGI ZZMQN 7X8 AAFWJ ABPXF ABZZY ACZKN ADKSD ADSXY AFBFQ AOQMC |
| ID | FETCH-LOGICAL-c5178-f01a3ac58a34da12de0281f62e3568dda1268e3e0edc1fad780376d465eddcfa2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 173 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000441143500024&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1531-5487 |
| IngestDate | Wed Oct 01 12:09:30 EDT 2025 Wed Feb 19 02:35:48 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c5178-f01a3ac58a34da12de0281f62e3568dda1268e3e0edc1fad780376d465eddcfa2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | http://links.lww.com/EDE/B356 |
| PMID | 29847496 |
| PQID | 2047926365 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2047926365 pubmed_primary_29847496 |
| PublicationCentury | 2000 |
| PublicationDate | 2018-09-01 |
| PublicationDateYYYYMMDD | 2018-09-01 |
| PublicationDate_xml | – month: 09 year: 2018 text: 2018-09-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Epidemiology (Cambridge, Mass.) |
| PublicationTitleAlternate | Epidemiology |
| PublicationYear | 2018 |
| References | 30648981 - Epidemiology. 2019 Mar;30(2):e13 |
| References_xml | – reference: 30648981 - Epidemiology. 2019 Mar;30(2):e13 |
| SSID | ssj0017315 |
| Score | 2.616433 |
| Snippet | Recent research on the US opioid epidemic has focused on the white or total population and has largely been limited to data after 1999. However, understanding... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 707 |
| SubjectTerms | Adolescent Adult African Americans - statistics & numerical data Age Factors Aged Aged, 80 and over Cause of Death Child Child, Preschool European Continental Ancestry Group - statistics & numerical data Heroin Dependence - mortality Humans Infant Infant, Newborn Middle Aged Opioid-Related Disorders - mortality United States - epidemiology Young Adult |
| Title | Trends in Black and White Opioid Mortality in the United States, 1979-2015 |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/29847496 https://www.proquest.com/docview/2047926365 |
| Volume | 29 |
| WOSCitedRecordID | wos000441143500024&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1JS8QwFA7qeBDEfRk3Ini02CRNk5xEdAYRZ5yDytxKzAK9tKOj_n5fmpY5CYKF9lBaaF_e8r0l7yF0Ac6ae9PBO8m8AQdFq0SBZU28djrl3lradPt8fRTjsZxO1aQNuM3bsspOJzaK2tYmxMjBSc-EojnL-fXsPQlTo0J2tR2hsYx6DKBM4GoxXWQRRJxgAEJNkoDMu61zSlwN7gaxdWF3SC5_B5mNsRlu_vczt9BGCzPxTeSLbbTkqh20HmN0OG492kUPsSAWlxVu4nhYVxY3E_Pw06ysS4tHDTgHoB6eAaiII0TFEaJeYqKEAgkgfA-9DAfPt_dJO1shMZzA0viUaKYNl5plVhNqHQAN4nPqGM-lDbdy6ZhLnTXEaytkCqrIZjl31hqv6T5aqerKHSJsqIPFTn3G4LSCSflGbCq8IeCK6Mz30XlHqgJ4NyQkdOXqr3mxIFYfHUR6F7PYZKOgCuxmpvKjP7x9jNbgV2Us_TpBPQ-S607Rqvn-LOcfZw1TwHU8Gf0AFNa-Jg |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Trends+in+Black+and+White+Opioid+Mortality+in+the+United+States%2C+1979-2015&rft.jtitle=Epidemiology+%28Cambridge%2C+Mass.%29&rft.au=Alexander%2C+Monica+J&rft.au=Kiang%2C+Mathew+V&rft.au=Barbieri%2C+Magali&rft.date=2018-09-01&rft.issn=1531-5487&rft.eissn=1531-5487&rft.volume=29&rft.issue=5&rft.spage=707&rft_id=info:doi/10.1097%2FEDE.0000000000000858&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1531-5487&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1531-5487&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1531-5487&client=summon |